Adma Biologics (ADMA) Revenue Growth (1y) (2012 - 2025)
Adma Biologics (ADMA) Revenue Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 35.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | 18.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.39% |
| Sep 30, 2025 | 12.00% |
| Jun 30, 2025 | 13.80% |
| Mar 31, 2025 | 40.22% |
| Dec 31, 2024 | 59.06% |
| Sep 30, 2024 | 8.94% |
| Jun 30, 2024 | 78.29% |
| Mar 31, 2024 | 43.86% |
| Dec 31, 2023 | 47.86% |
| Sep 30, 2023 | 167.70% |
| Jun 30, 2023 | -19.84% |
| Mar 31, 2023 | 95.56% |
| Dec 31, 2022 | -9.12% |
| Sep 30, 2022 | 98.69% |
| Jun 30, 2022 | 320.63% |
| Mar 31, 2022 | 81.34% |
| Dec 31, 2021 | 294.09% |
| Sep 30, 2021 | 101.24% |
| Jun 30, 2021 | 128.96% |
| Mar 31, 2021 | 57.34% |